Thanks @vrs37, I meant OSL (although similar complaints could be levelled at RAP). Apologies to the forum for the error.
I agree with your comments. For me, the next few months will be a watershed. If the sales don’t come and reimbursements finalised I cant see how the MD will salvage any credibility with the market.
I hold a number of stocks for which this quarter holds out the promise of significant catalysts but I think OSL are facing the toughest test.
GLTAH
OSL Price at posting:
12.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)